Karnataka gets four of the six genome sequencing labs approved by DBT
The Department of Biotechnology (DBT) has approved the inclusion of six private genomic sequencing labs into the Indian SARS-CoV-2 Genomics Consortium (INSACOG). The network of labs is identified by the government to sequence the coronavirus disease (Covid) samples. Four of these labs are from Karnataka.
The labs from Karnataka are Strand Life Sciences, Genotypic Technologies, Medgenome and Eurofins Genomics India, according to an official memorandum from the ministry of science and technology.
The communication from the Union government also stated that the inclusion of the 6 labs is subject to certain conditions like the sequencing charges are to be borne by the private labs and not passed on to the patients. Further, the labs would be required to indicate the source of funding in order to undertake sequencing activities.
The sequencing information will be confidential and would not be shared to any third party source or public. The private labs will need to preserve the RNA samples for a specific period, among other terms and conditions to ensure the quality of sequencing.
In December 2021, the Karnataka government to expedite diagnosis of the Omicron variant of SARS-CoV-2 virus set up additional genomic sequencing labs. This was in addition to the National Institute of Mental Health and Neuro Sciences (NIMHANS) and the National Centre for Biological Sciences (NCBS).
During the second wave of Covid-19, the state government had said six genome sequencing labs were being set up at Bengaluru, Mysuru, Shivamogga, Hubballi, Mangaluru and Vijayapura. These labs are expected to strengthen the diagnostic infrastructure in the state. This is because early detection is the key to faster isolation and treatment access, said Karnataka Chief Minister Basavaraj Bommai.
In the wake of the Omicron variant spread, the state took up measures to set up more genomic sequencing labs. Right now all of Karnataka
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!